Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Revenue

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹1,669 Cr₹1,541 Cr₹1,242 Cr₹1,107 Cr₹968 Cr

What is the latest Revenue of INDOCO REMEDIES ?

The latest Revenue ratio of INDOCO REMEDIES is ₹1,669 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,669 Cr
Mar2023₹1,541 Cr
Mar2022₹1,242 Cr
Mar2021₹1,107 Cr
Mar2020₹968 Cr

How is Revenue of INDOCO REMEDIES Trending?

Years Revenue % Change
Mar2024 ₹1,669 Cr
8.30
Mar2023 ₹1,541 Cr
24.10
Mar2022 ₹1,242 Cr
12.19
Mar2021 ₹1,107 Cr
14.26
Mar2020 ₹968 Cr -

Compare Revenue of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,858.7 Cr -8.2% 9.9% -3.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,712.0 Cr -1.3% 1% 7.9% Stock Analytics
DIVIS LABORATORIES ₹176,623.0 Cr -3.2% -0.3% 48% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,285.0 Cr 1.2% 10.7% 19.5% Stock Analytics
CIPLA ₹119,010.0 Cr -0.6% -2.2% -0.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,118.0 Cr -1.5% -5.9% -5.1% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-8.2%

9.9%

-3.4%

SENSEX

0.1%

1%

2.6%


You may also like the below Video Courses